Plasma lipoperoxidative markers in ischaemic stroke suggest brain embolism

Eur J Emerg Med. 1997 Mar;4(1):5-9.

Abstract

Plasma activity of myeloperoxidase (MPO), malondialdehyde (MDA) and 4-hydroxynonenal (HNE) was measured prior to any treatment in 50 consecutive stroke patients with acute cerebral ischaemia, as well as in 14 healthy control subjects. Mann-Whitney-Wilcoxon test for unpaired data showed greater values of MPO (p < 0.01), MDA (p < 0.01) and HNE (p < 0.05) in stroke patients compared with controls. Considering as covariates the level of consciousness (GCS < 9 vs > or = 9), possible sources of emboli (yes vs no), leukocyte count (< 10 x 10(9)/1 vs > or = 10 x 10(9)/1) and relevant comorbid diseases (yes vs no), exact multiple logistic regression analysis indicated that only the presence of possible cardiac sources of emboli was associated with changes in by-products of lipid peroxidation. If confirmed in a larger series of subjects, our results could have therapeutic implications, providing more support for the use of free radical scavengers in the acute care of stroke patients with a possible cardioembolic aetiology.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aldehydes / blood*
  • Aldehydes / metabolism
  • Biomarkers / blood
  • Brain Ischemia / complications
  • Brain Ischemia / diagnosis*
  • Brain Ischemia / enzymology
  • Diagnosis, Differential
  • Emergency Service, Hospital
  • Female
  • Humans
  • Intracranial Embolism and Thrombosis / diagnosis*
  • Intracranial Embolism and Thrombosis / enzymology
  • Intracranial Embolism and Thrombosis / etiology
  • Logistic Models
  • Male
  • Malondialdehyde / blood*
  • Malondialdehyde / metabolism
  • Peroxidase / blood*
  • Peroxidase / metabolism
  • Sensitivity and Specificity

Substances

  • Aldehydes
  • Biomarkers
  • Malondialdehyde
  • Peroxidase
  • 4-hydroxy-2-nonenal